Hope on the horizon: how pegbelfermin offers a glimmer of hope for NASH sufferers? Authors Sawairah Mukhtiar 5th Year MBBS Student, Dow International Medical College, Karachi, Pakistan Nisha Babar 5th Year MBBS Student, Dow International Medical College, Karachi, Pakistan Fatima Rehan 5th Year MBBS Student, Dow International Medical College, Karachi, Pakistan DOI: https://doi.org/10.47391/JPMA.9769 Abstract Madam, Non-alcoholic steatohepatitis (NASH), is described as having hepatic steatosis of >5%, inflammation, and hepatocyte damage (such as ballooning), including or excluding fibrosis¹. NASH falls under a group of liver diseases termed Non-alcoholic Fatty Liver Disease (NAFLD) varying from benign steatosis to inflammatory NASH and hepatic fibrosis. ---Continue Downloads Full Text Article Published 2023-11-28 How to Cite Mukhtiar, S., Nisha Babar, & Fatima Rehan. (2023). Hope on the horizon: how pegbelfermin offers a glimmer of hope for NASH sufferers?. Journal of the Pakistan Medical Association, 73(12), 2526–2527. https://doi.org/10.47391/JPMA.9769 More Citation Formats ACM ACS APA ABNT Chicago Harvard IEEE MLA Turabian Vancouver Download Citation Endnote/Zotero/Mendeley (RIS) BibTeX Issue Vol. 73 No. 12 (2023): DECEMBER Section LETTER TO THE EDITOR License Copyright (c) 2023 Journal of the Pakistan Medical Association This work is licensed under a Creative Commons Attribution 4.0 International License.